AlloVir (ALVR)
NASDAQ:ALVR
US Market

AlloVir (ALVR) Stock Price & Analysis

161 Followers

ALVR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.17 - $10.29
Previous Close$5.78
Volume249.19K
Average Volume (3M)243.15K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$264.11M
Total Debt (Recent Filing)$21.67M
Price to Earnings (P/E)-2.1
Beta0.23
Next EarningsFeb 09, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-2.78
Shares Outstanding62,669,373
R-Squared0.04
Standard Deviation0.24
10 Day Avg. Volume206,241
30 Day Avg. Volume243,146
Price to Book (P/B)1.88
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside243.93% Upside
Rating ConsensusStrong Buy
Alpha-0.03
Number of Analyst Covering3


Financials

Annual

ALVR FAQ

What was AlloVir’s price range in the past 12 months?
AlloVir lowest stock price was $3.17 and its highest was $10.29 in the past 12 months.
    What is AlloVir’s market cap?
    Currently, no data Available
    When is AlloVir’s upcoming earnings report date?
    AlloVir’s upcoming earnings report date is Feb 09, 2023 which is in 7 days.
      How were AlloVir’s earnings last quarter?
      AlloVir released its earnings results on Nov 03, 2022. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.517 by $0.017.
        Is AlloVir overvalued?
        According to Wall Street analysts AlloVir’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AlloVir pay dividends?
          AlloVir does not currently pay dividends.
          What is AlloVir’s EPS estimate?
          AlloVir’s EPS estimate is -$0.51.
            How many shares outstanding does AlloVir have?
            AlloVir has 93,162,964 shares outstanding.
              What happened to AlloVir’s price movement after its last earnings report?
              AlloVir reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.517. Following the earnings report the stock price went down -1.28%.
                Which hedge fund is a major shareholder of AlloVir?
                Among the largest hedge funds holding AlloVir’s share is GMT Capital Corp. It holds AlloVir’s shares valued at 22M.

                  ---

                  AlloVir Stock Smart Score

                  8
                  Outperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -26.14%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -72.43%
                  Trailing 12-Months
                  Asset Growth
                  -7.21%
                  Trailing 12-Months
                  The AlloVir stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  AlloVir

                  AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  iTeos Therapeutics
                  Mirum Pharmaceuticals
                  Editas Medicine
                  Allakos
                  Mersana Therapeutics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis